View Future GrowthPrologue 과거 순이익 실적과거 기준 점검 5/6Prologue은 연평균 40.2%의 비율로 수입이 증가해 온 반면, Software 산업은 수입이 10.4% 증가했습니다. 매출은 연평균 0.8%의 비율로 증가했습니다. Prologue의 자기자본이익률은 37.7%이고 순이익률은 14.7%입니다.핵심 정보40.23%순이익 성장률41.45%주당순이익(EPS) 성장률Software 산업 성장률14.88%매출 성장률0.84%자기자본이익률37.65%순이익률14.75%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공지 • Jul 02Archos S.A. (ENXTPA:ALJXR) completed the acquisition of O2i Ingénierie from Prologue S.A. (ENXTPA:ALPRG).Archos S.A. (ENXTPA:ALJXR) signed a letter of intent to acquire O2i Ingénierie from Prologue S.A. (ENXTPA:ALPRG) for €0.3 million on May 27, 2025. A cash consideration of €0.3 million will be paid by Archos S.A. As part of consideration, €0.3 million is paid towards common equity of O2i Ingénierie. For the period ending December 31, 2024, O2i Ingénierie reported total revenue of €11 million. The transaction remains subject to consultation with Prologue's employee representative bodies, approval, and the signing of definitive documentation, and is expected to be finalized by July 1, 2025. Archos S.A. (ENXTPA:ALJXR) completed the acquisition of O2i Ingénierie from Prologue S.A. (ENXTPA:ALPRG) on July 1, 2025.공지 • May 17Prologue S.A., Annual General Meeting, Jun 24, 2025Prologue S.A., Annual General Meeting, Jun 24, 2025. Location: 101 avenue laurent cely, gennevilliers FranceNew Risk • Oct 18New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (€15.9m market cap, or US$17.3m).New Risk • May 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€18.6m market cap, or US$20.1m).공지 • May 12Prologue S.A., Annual General Meeting, Jun 27, 2024Prologue S.A., Annual General Meeting, Jun 27, 2024. Location: 101 avenue laurent cely, gennevilliers FranceNew Risk • Apr 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€15.0m market cap, or US$16.3m).New Risk • Nov 05New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (€20.7m market cap, or US$22.2m).New Risk • Jul 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (€19.4m market cap, or US$21.2m).Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Annik Harmand was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Breakeven Date Change • Oct 04Forecast breakeven date pushed back to 2023The analyst covering Prologue previously expected the company to break even in 2022. New forecast suggests losses will reduce by 78% to 2022. The company is expected to make a profit of €20.0k in 2023. Average annual earnings growth of 110% is required to achieve expected profit on schedule.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Annik Harmand was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2022The analyst covering Prologue previously expected the company to break even in 2021. New forecast suggests the company will make a profit of €2.14m in 2022. Average annual earnings growth of 108% is required to achieve expected profit on schedule.Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering Prologue expects the company to break even for the first time. New forecast suggests the company will make a profit of €2.81m in 2021. Earnings growth of 64% is required to achieve expected profit on schedule.매출 및 비용 세부 내역Prologue가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:69P 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 2567100030 Sep 258110-1030 Jun 259494031 Mar 2510364031 Dec 2411125030 Sep 2411102030 Jun 24111-35031 Mar 24111-66031 Dec 23112-106030 Sep 23113-87030 Jun 23113-66031 Mar 23111-36031 Dec 2210915030 Sep 2210722030 Jun 2210313031 Mar 229904031 Dec 2196-15030 Sep 2192-39030 Jun 2190-29031 Mar 2185-29031 Dec 2079-18030 Sep 2080-29030 Jun 2080-29031 Mar 2084-210031 Dec 1987-210030 Sep 1988-212030 Jun 1989-213031 Mar 1987-114031 Dec 1886-114030 Jun 1878012031 Mar 1877-114031 Dec 1777-315030 Jun 1779-619031 Mar 1777-517031 Dec 1675-515030 Sep 1672-413030 Jun 1669-311031 Mar 1658-39031 Dec 1546-37030 Sep 1535-37030 Jun 1523-230양질의 수익: 69P의 비현금 수익 수준이 높습니다.이익 마진 증가: 69P의 현재 순 이익률 (14.7%)은 지난해 (1.8%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 69P는 지난 5년 동안 흑자전환하며 연평균 40.2%의 수익 성장을 기록했습니다.성장 가속화: 지난 1년간 69P 의 수익 증가율(397%)은 연간 평균(40.2%)을 초과합니다.수익 대 산업: 69P의 지난 1년 수익 증가율(397%)은 Software 업계의 26.7%를 상회했습니다.자기자본이익률높은 ROE: 69P의 자본 수익률(37.7%)은 높음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSoftware 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 18:43종가2026/05/07 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Prologue S.A.는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Loic WolfGreenSome Finance
공지 • Jul 02Archos S.A. (ENXTPA:ALJXR) completed the acquisition of O2i Ingénierie from Prologue S.A. (ENXTPA:ALPRG).Archos S.A. (ENXTPA:ALJXR) signed a letter of intent to acquire O2i Ingénierie from Prologue S.A. (ENXTPA:ALPRG) for €0.3 million on May 27, 2025. A cash consideration of €0.3 million will be paid by Archos S.A. As part of consideration, €0.3 million is paid towards common equity of O2i Ingénierie. For the period ending December 31, 2024, O2i Ingénierie reported total revenue of €11 million. The transaction remains subject to consultation with Prologue's employee representative bodies, approval, and the signing of definitive documentation, and is expected to be finalized by July 1, 2025. Archos S.A. (ENXTPA:ALJXR) completed the acquisition of O2i Ingénierie from Prologue S.A. (ENXTPA:ALPRG) on July 1, 2025.
공지 • May 17Prologue S.A., Annual General Meeting, Jun 24, 2025Prologue S.A., Annual General Meeting, Jun 24, 2025. Location: 101 avenue laurent cely, gennevilliers France
New Risk • Oct 18New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (€15.9m market cap, or US$17.3m).
New Risk • May 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€18.6m market cap, or US$20.1m).
공지 • May 12Prologue S.A., Annual General Meeting, Jun 27, 2024Prologue S.A., Annual General Meeting, Jun 27, 2024. Location: 101 avenue laurent cely, gennevilliers France
New Risk • Apr 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€15.0m market cap, or US$16.3m).
New Risk • Nov 05New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (€20.7m market cap, or US$22.2m).
New Risk • Jul 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (€19.4m market cap, or US$21.2m).
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Annik Harmand was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Breakeven Date Change • Oct 04Forecast breakeven date pushed back to 2023The analyst covering Prologue previously expected the company to break even in 2022. New forecast suggests losses will reduce by 78% to 2022. The company is expected to make a profit of €20.0k in 2023. Average annual earnings growth of 110% is required to achieve expected profit on schedule.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Annik Harmand was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Breakeven Date Change • Dec 31Forecast breakeven date pushed back to 2022The analyst covering Prologue previously expected the company to break even in 2021. New forecast suggests the company will make a profit of €2.14m in 2022. Average annual earnings growth of 108% is required to achieve expected profit on schedule.
Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering Prologue expects the company to break even for the first time. New forecast suggests the company will make a profit of €2.81m in 2021. Earnings growth of 64% is required to achieve expected profit on schedule.